HOUSTON, Aug. 10, 2024 /PRNewswire/ — On August 8, 2024, SEG Solar (SEG), a leading U.S. photovoltaic manufacturer, held a grand opening ceremony for its new PV manufacturing base in Houston, Texas, marking a new chapter in SEG’s commitment to U.S. domestic manufacturing. During the ceremony, the first 585W YUKON N series module rolled off the […]
Category Archives: Pr Newswire
Strong Revenue Growth and Strategic Advances Across Key Segments, Enhances Commitment to ESG and Sustainable Development Impressive Financial Growth: The group reported a 43.5% increase in revenue, driven by a 156% boost in cell therapy revenue and a 75.4% rise in gross profit, showcasing strong performance across key segments. Focused on Innovation and Efficiency: Investing […]
NEW YORK, Aug. 9, 2024 /PRNewswire/ — Global IBO Group Ltd. (“GIBO”), a unique and integrated AIGC animation creation and streaming platform for storytellers and content creators, and Bukit Jalil Global Acquisition 1 Ltd. (“Bukit Jalil Global”) (Nasdaq: BUJA), a publicly traded special purpose acquisition company, today announced that they have entered into a definitive […]
LONDON and NEW YORK, Aug. 9, 2024 /PRNewswire/ — Today, i2 Group said increasing demand for its intelligence analytics software among NATO forces and intelligence and law enforcement agencies was driving the company’s double-digit growth. The global leader in visual data analysis today reported an annual 18% uptick in software license sales and 10% workforce growth as […]
BEIJING, Aug. 9, 2024 /PRNewswire/ — Power Construction Corporation of China (“POWERCHINA” or “the Company”) continues to do its part to alleviate the harsh summer climate change challenges affecting many regions worldwide. The Company’s series of construction projects and actions have enhanced the flood control and drought resistance capabilities of various regions in Americas, Africa, and Asia, […]
09
Aug
Aug
Tigris Trial Enrollment Reaches 126 Patients Strengthened Balance Sheet with Expected Funds to Complete Tigris Trial Enrollment TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the second quarter ended […]
09
Aug
Aug
Conference call will be held today, Friday, August 9 at 9:00 am ET Carmel, Ind., Aug. 09, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the second quarter period ended […]
Pr Newswire
Elucent Medical Announces Froedtert & the Medical College of Wisconsin Health Network to Provide New Breast Cancer Surgical Technology
09
Aug
Aug
EDEN PRAIRIE, Minn., Aug. 09, 2024 (GLOBE NEWSWIRE) — Elucent Medical, a pioneering medical technology company transforming the field of guided surgical technology, is thrilled to announce Froedtert & the Medical College of Wisconsin health network with the Elucent Medical advanced In-Body Spatial Intelligence (iSi) systems for breast cancer surgery. This new technology is expected […]
09
Aug
Aug
SAN CLEMENTE, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference on August 12 […]
Pr Newswire
Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
09
Aug
Aug
Initiated and Enrolling Patients into MNPR-101-Zr First-in-Human Phase 1 Radiopharma Clinical Trial MNPR-101 radio-immuno-therapeutic (RIT) Clinical Trial on Track to Initiate in Q4 2024 WILMETTE, Ill., Aug. 09, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, today announced […]